Henric Malmström

Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer.

W ten Bokkel Huinink, Martin Gore, J Carmichael et al. · Journal of Clinical Oncology · 1997 · 683 citations

Medicine, Oncology, Pharmacology +17

Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)

Nicholas Reed, Costantino Mangioni, Henric Malmström et al. · European Journal of Cancer · 2008 · 531 citations

Medicine, Oncology, Radiation Oncology +13

Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel.

M. A. Bookman, Henric Malmström, Giorgio Bolis et al. · Journal of Clinical Oncology · 1998 · 334 citations

Medicine, Oncology, Pharmacotherapy +16

Granulosa Cell Tumors of the Ovary: Prognostic Factors and Outcome

Henric Malmström, Thomas Högberg, Bjørn Risberg et al. · Gynecologic Oncology · 1994 · 261 citations

Medicine, Gynecology, Oncology +14

Clinical Evidence for Topotecan-Paclitaxel Non–Cross-Resistance in Ovarian Cancer

Martin Gore, W ten Bokkel Huinink, James Carmichael et al. · Journal of Clinical Oncology · 2001 · 93 citations

Medicine, Oncology, Pharmacology +17